company background image
JBCHEPHARM logo

J. B. Chemicals & Pharmaceuticals NSEI:JBCHEPHARM Voorraadrapport

Laatste prijs

₹1.75k

Marktkapitalisatie

₹271.5b

7D

5.0%

1Y

25.6%

Bijgewerkt

26 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM Voorraadrapport

Marktkapitalisatie: ₹271.5b

JBCHEPHARM Overzicht aandelen

J. B. Chemicals & Pharmaceuticals Limited produceert en verkoopt farmaceutische formuleringen, kruidengeneesmiddelen en actieve farmaceutische ingrediënten (API) in India en daarbuiten. Meer informatie

JBCHEPHARM fundamentele analyse
Sneeuwvlok Score
Waardering2/6
Toekomstige groei4/6
Prestaties in het verleden5/6
Financiële gezondheid6/6
Dividenden4/6

J. B. Chemicals & Pharmaceuticals Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor J. B. Chemicals & Pharmaceuticals
Historische aandelenkoersen
Huidige aandelenkoers₹1,749.70
52 Week Hoogtepunt₹2,030.00
52 Week Laag₹1,371.00
Bèta-0.016
11 maand verandering-7.52%
3 maanden verandering-11.14%
1 Jaar Verandering25.62%
33 jaar verandering113.55%
5 jaar verandering766.51%
Verandering sinds IPO2,216.72%

Recent nieuws en updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Recent updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Sep 24
J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Aug 15
Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 11
J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Rendement voor aandeelhouders

JBCHEPHARMIN PharmaceuticalsIN Markt
7D5.0%1.1%2.0%
1Y25.6%43.3%28.6%

Rendement versus industrie: JBCHEPHARM presteerde slechter dan de Indian Pharmaceuticals -sector, die het afgelopen jaar een rendement van 43.3 % opleverde.

Rendement versus markt: JBCHEPHARM presteerde slechter dan Indian Market, dat het afgelopen jaar een rendement van 28.6 % opleverde.

Prijsvolatiliteit

Is JBCHEPHARM's price volatile compared to industry and market?
JBCHEPHARM volatility
JBCHEPHARM Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Stabiele aandelenkoers: JBCHEPHARM heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van JBCHEPHARM is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19765,311Nikhil Choprawww.jbpharma.com

J. B. Chemicals & Pharmaceuticals Limited produceert en verkoopt farmaceutische formuleringen, kruidengeneesmiddelen en actieve farmaceutische ingrediënten (API) in India en daarbuiten. Het productassortiment van het bedrijf omvat diclofenac-natrium, diethylamine, zuur en kalium; nifedipine, atenolol en cilnidipine; en ciprofloxacine, cetirizine en meclizine HCI. Het biedt ook toedieningsvormen, zoals tabletten, zuigtabletten, injecteerbare middelen, gels, crèmes, zalven, vloeibare kruidensiropen, verkoudheidsmiddelen, oogdruppels, troches en capsules; en zuigtabletten met een zachte kern, poeder, medicinale zuigtabletten en zuigtabletten op basis van kruiden, evenals verschillende farmaceutische toedieningsvormen.

J. B. Chemicals & Pharmaceuticals Limited Samenvatting

Hoe verhouden de winst en inkomsten van J. B. Chemicals & Pharmaceuticals zich tot de beurswaarde?
JBCHEPHARM fundamentele statistieken
Marktkapitalisatie₹271.45b
Inkomsten(TTM)₹6.11b
Inkomsten(TTM)₹37.11b

44.4x

Koers/Winstverhouding

7.3x

P/S-verhouding

Is JBCHEPHARM overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
JBCHEPHARM resultatenrekening (TTM)
Inkomsten₹37.11b
Kosten van inkomsten₹12.84b
Brutowinst₹24.27b
Overige uitgaven₹18.16b
Inkomsten₹6.11b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)39.35
Brutomarge65.40%
Nettowinstmarge16.47%
Schuld/Eigen Vermogen Verhouding2.5%

Hoe presteerde JBCHEPHARM op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.8%

Huidig dividendrendement

17%

Uitbetalingsratio